Briacell Therapeutics Corp (BCTX) Live Share Price, Invest From India

Briacell Therapeutics Corp Stock Performance

as on April 14, 2026 at 6:59 am IST

Day's Low
Day's High
$4.20
Day's Price Range
$4.50
$4.40
4.55%
Downside
2.27%
Upside
52 Week's Low
52 Week's High
$3.60
52-Week Price Range
$98.20
$4.40
18.18%
Downside
2131.82%
Upside

Briacell Therapeutics Corp share price movements today

Previous Close: $4.28
Open: $4.26
Volume: 319.6K
Day's Low - High: $4.20 - $4.50
52 Week Low - High: $3.60 - $98.20

Briacell Therapeutics Corp Historical Returns

1 Month Return: + 3.79 %
3 Month Return: -9.88 %
1 Year Return: -90 %
3 Year Return: -99.59 %
5 Year Return: -99.09 %

Briacell Therapeutics Corp Stock Fundamentals & Key Indicators

Check Briacell Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.0M

EPS (TTM)

-11.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-30.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-179.21%

Briacell Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Briacell Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Briacell Therapeutics Corp	BUY	$31.0M	-99.09%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$42.7B	140.76%	138.84	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.0B	102.67%	28.5	32.94%
BeiGene, Ltd.	NA	$35.6B	NA	124.86	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.2B	55.14%	18.05	31.41%

Stock Returns calculator for Briacell Therapeutics Corp Stock including INR - Dollar returns

The Briacell Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Briacell Therapeutics Corp investment value today

Current value as on today

₹10,897

Returns

-₹89,103

(-89.1%)

Returns from Briacell Therapeutics Corp Stock

-₹89,954 (-89.95%)

Dollar Impact

₹851 (+0.85%)

Analyst Recommendation on Briacell Therapeutics Corp Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Briacell Therapeutics Corp. Average target price of $150

Briacell Therapeutics Corp Share Price Target

Get share price movements and forecasts by analysts on Briacell Therapeutics Corp.

What analysts predicted

97.07%UPSIDE

Target Price

$150

Current Price

$4.4

Analyzed by

5 Analysts

Target

$150.00

Briacell Therapeutics Corp target price $150, a slight upside of 97.07% compared to current price of $4.4. According to 5 analysts rating.

Briacell Therapeutics Corp Stock’s Investor Sentiment and Interest

Search interest for Briacell Therapeutics Corp Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 15, 2026 to April 14, 2026

Change:-7% versus previous 30 day period

Briacell Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-11	-13	-12	-7	-7	-10	-9	-11	-11	-7
EBITDA	8	-15	2	-1	-7	-9	-8	-11	-11	-7
Interest Expense	-	-	-	-	-	-	0	-	-	-
Depreciation	0	0	0	0	0	0	0	-	0	0
Income Before Tax	8	-15	2	-1	-7	-9	-8	-11	-11	-7
Income Tax Expense	-14	1	-10	0	-	-	-	-	-	-
Net Income	8	-15	2	-1	-7	-9	-8	-11	-11	-7
Net Profit Margin	0.00%	0.00%	0.00%	-7373.74%	0.00%	0.00%	0.00%	-4906.92%	0.00%	0.00%

Briacell Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-4	-6	-4	-8	-19	-31	-45
EBITDA	-5	-5	-4	-17	-34	-27	-6
Interest Expense	0	0	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-5	-5	-4	-17	-34	-27	-6
Income Tax Expense	0	0	0	6	0	0	0
Net Income	-5	-5	-4	-17	-34	-27	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Briacell Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Net Income	-15	2	-1	-7	-9	-8	-11	-11	-4
Operating Cash Flow	-10	-6	-5	-9	-8	-10	-11	-10	-8
Investing Cash Flow	-	0	0	0	0	0	-10	0	7
Financing Cash Flow	-	-	6	16	7	20	18	-	28
Change in Cash	-10	-7	0	6	-1	10	-2	-10	27

Briacell Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Jul 2017	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024	Jul 2025
Net Income	-3	-5	-5	-4	-17	-34	-27	-6	-36
Operating Cash Flow	-1	-4	-5	-1	-9	-15	-31	-32	-39
Investing Cash Flow	0	0	1	-	-	-	-	0	-10
Financing Cash Flow	2	5	3	1	82	-4	5	6	63
Change in Cash	1	0	0	0	71	-20	-26	-28	13

Global Institutional Holdings in Briacell Therapeutics Corp

Funds	Holdings
UBS Group AG	0%
Advisor Group Holdings, Inc.	0%
Wells Fargo & Co	0%
Susquehanna International Group, LLP	0%
Advisor Group Holdings, Inc.	0%

See all

Briacell Therapeutics Corp News & Key Events

Insights on Briacell Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.0% return, outperforming this stock by 157.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 34.2% return, outperforming this stock by 124.4%
NEGATIVE IMPACT
Price Dip
In the last 6 months, BCTX stock has moved down by -62.5%

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Organisation	Briacell Therapeutics Corp
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Industry	Biotechnology
CEO	Dr. William V. Williams FCPA, M.D.
E-voting on shares	Click here to vote

Key Management of Briacell Therapeutics Corp

Name	Title
Dr. William V. Williams FCPA, M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H.	Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board

FAQs

What is Briacell Therapeutics Corp share price today?

Briacell Therapeutics Corp share price today is $4.4 as on April 14, 2026 at 1:29 am IST at the close of the market. Briacell Therapeutics Corp share today touched a day high of $4.5 and a low of $4.2.

What is the 52 week high and 52 week low for Briacell Therapeutics Corp share?

Briacell Therapeutics Corp share touched a 52 week high of $98.2 on April 24, 2025 and a 52 week low of $3.6 on February 24, 2026. Briacell Therapeutics Corp stock price today i.e. April 14, 2026 at 1:29 am IST is closed at $4.4,which is 95.52% down from its 52 week high and 22.22% up from its 52 week low.

What is Briacell Therapeutics Corp's market capitalisation today?

Briacell Therapeutics Corp market capitalisation is $0.00T as on April 14, 2026 at 1:29 am IST.

How to invest in Briacell Therapeutics Corp Stock (BCTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Briacell Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Briacell Therapeutics Corp Shares that will get you 0.3409 shares as per Briacell Therapeutics Corp share price of $4.4 per share as on April 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy Briacell Therapeutics Corp Stock (BCTX) from India?

Indian investors can start investing in Briacell Therapeutics Corp (BCTX) shares with as little as ₹93.337 or $1 (as of April 14, 2026 at 9:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹933.37 in Briacell Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on April 14, 2026 at 9:41 am IST). Based on Briacell Therapeutics Corp share’s latest price of $4.4 as on April 14, 2026 at 1:29 am IST, you will get 2.2727 shares of Briacell Therapeutics Corp. Learn more about fractional shares .

What are the returns that Briacell Therapeutics Corp has given to Indian investors in the last 5 years?

Briacell Therapeutics Corp stock has given -99.09% share price returns and 23.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?